Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines
Chronic myeloid leukemia (CML) is a myeloproliferative haematological malignancy characterized by constitutive activation of BCR-ABL1 tyrosine kinase in the majority of patients. BCR-ABL1 expression activates signaling pathways involved in cell proliferation and survival. Current treatment options f...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2022-12-01
|
| Series: | Metabolites |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2218-1989/13/1/58 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|